Legend Biotech shares decline as market pressures mount

news.yahoo.com

Legend Biotech Corporation (NASDAQ: LEGN) shares have faced pressure, losing 41.12% over the past year. As of February 20, 2025, the stock closed at $38.92, with a market cap of $7.14 billion. Meridian Funds highlighted Legend Biotech in its Q4 2024 investor letter, noting a one-month return of 5.45%. However, the fund's focus has shifted towards AI stocks, which they believe offer better potential for returns. The number of hedge funds holding Legend Biotech increased from 31 to 36 in the last quarter of 2024. Despite this, the company is not among the top 30 most popular stocks among hedge funds.


With a significance score of 2.2, this news ranks in the top 21% of today's 30721 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: